Tag: PD-1 and PD-L1 inhibitors

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to PD-1 and PD-L1 inhibitors

Aptevo Therapeutics Provides Program Update for Bispecific APVO711, a PD-L1 X CD40 ...

Added to Collection on: 2025-05-08 13:53:37

Tags for this article:

Immune system
Clusters of differentiation
Cancer immunotherapy
Virotherapy
Immunotherapy
PD-L1
Programmed cell death protein 1
Checkpoint inhibitor
TPBG
Bispecific monoclonal antibody
PD-1 and PD-L1 inhibitors
Aptevo Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
First dog receives combination immunotherapy in new cancer trial - DVM360

Added to Collection on: 2025-07-16 21:19:35

Tags for this article:

Immune system
Clusters of differentiation
Cancer immunotherapy
Checkpoint inhibitor
Immune checkpoint
Programmed cell death protein 1
Monoclonal antibodies
Immunotherapy
Cytotoxic T-lymphocyte associated protein 4
PD-1 and PD-L1 inhibitors
Adobe

Click the tags to see associated articles and topics

View Article Details
Will Increased Expenses Affect Bristol Myers' Performance? - The Globe and Mail

Added to Collection on: 2025-07-16 14:10:11

Tags for this article:

Cancer immunotherapy
Pfizer
Research and development in the United States
Merck & Co.
Bristol-Myers Squibb
Securities research
BioNTech
Pharmaceutical industry
PD-1 and PD-L1 inhibitors
Programmed cell death protein 1

Click the tags to see associated articles and topics

View Article Details
AKESO (09926.HK): Leading the global IO2.0, Evarosi is expected to occupy the largest market share

Added to Collection on: 2025-08-09 07:48:50

Tags for this article:

Lung cancer
Angiogenesis
Vascular endothelial growth factor
Non-small-cell lung cancer
Programmed cell death protein 1
PD-1 and PD-L1 inhibitors
Targeted therapy

Click the tags to see associated articles and topics

View Article Details
BMY-BioNTech Partnership: A Potential Catalyst for Long-Term Gains? - Yahoo Finance

Added to Collection on: 2025-09-13 11:31:47

Tags for this article:

Cancer immunotherapy
Lung cancer
Immune system
Clusters of differentiation
Orphan drugs
Checkpoint inhibitor
Pembrolizumab
PD-1 and PD-L1 inhibitors
Small-cell carcinoma
Vascular endothelial growth factor
Programmed cell death protein 1
PD-L1
BioNTech
Bristol Myers

Click the tags to see associated articles and topics

View Article Details
BMY-BioNTech Partnership: A Potential Catalyst for Long-Term Gains? - sharewise

Added to Collection on: 2025-09-13 04:58:16

Tags for this article:

Cancer immunotherapy
Immune system
Lung cancer
Orphan drugs
Pfizer
Pembrolizumab
Checkpoint inhibitor
Bristol-Myers Squibb
PD-1 and PD-L1 inhibitors
BioNTech
Merck & Co.
Programmed cell death protein 1
Bristol-Myers Squibb Company
Bristol Myers

Click the tags to see associated articles and topics

View Article Details
Jazz, Roche combo cleared by FDA for lung cancer - pharmaphorum

Added to Collection on: 2025-10-03 14:07:13

Tags for this article:

Lung cancer
Orphan drugs
Antineoplastic drugs
Cervix
Small-cell carcinoma
Atezolizumab
Durvalumab
PD-1 and PD-L1 inhibitors
lurbinectedin
Combined small-cell lung carcinoma
TIGIT
JAZZ PHARMA

Click the tags to see associated articles and topics

View Article Details
FDA approves atezolizumab–lurbinectedin for ES-SCLC

Added to Collection on: 2025-10-05 05:52:34

Tags for this article:

Orphan drugs
Acetate esters
Antineoplastic drugs
Lung cancer
lurbinectedin
Atezolizumab
PD-1 and PD-L1 inhibitors
PD-L1
Immunotherapy
Trabectedin
TIGIT

Click the tags to see associated articles and topics

View Article Details
Overcoming resistance to anti-PD-L1 immunotherapy: mechanisms, combination strategies ...

Added to Collection on: 2025-10-08 01:34:14

Tags for this article:

Clusters of differentiation
Programmed cell death protein 1
PD-L1
Immunotherapy
Tumor-infiltrating lymphocytes
L1
PD-1 and PD-L1 inhibitors
Cancer immunotherapy

Click the tags to see associated articles and topics

View Article Details
Arbutus Biopharma to Present New Data on Imdusiran and AB-101 at AASLD 2025

Added to Collection on: 2025-10-12 22:19:56

Tags for this article:

Cancer immunotherapy
Antiviral drugs
Clusters of differentiation
Infectious causes of cancer
Immune system
PD-1 and PD-L1 inhibitors
PD-L1
Interferon
Hepatitis B
Hepatitis
HBsAg
Arbutus Biopharma

Click the tags to see associated articles and topics

View Article Details
Book a Demo